We used the Immunochip array to analyze 2,816 individuals with juvenile idiopathic arthritis (JIA), comprising the most common subtypes (oligoarticular and rheumatoid factor-negative polyarticular JIA), and 13,056 controls. We confirmed association of 3 known JIA risk loci (the human leukocyte antigen (HLA) region, PTPN22 and PTPN2) and identified 14 loci reaching genome-wide significance (P < 5 × 10 −8 ) for the first time. Eleven additional new regions showed suggestive evidence of association with JIA (P < 1 × 10 −6 ). Dense mapping of loci along with bioinformatics analysis refined the associations to one gene in each of eight regions, highlighting crucial pathways, including the interleukin (IL)-2 pathway, in JIA disease pathogenesis. The entire Immunochip content, the HLA region and the top 27 loci (P < 1 × 10 −6 ) explain an estimated 18, 13 and 6% of the risk of JIA, respectively. In summary, this is the largest collection of JIA cases investigated so far and provides new insight into the genetic basis of this childhood autoimmune disease.
l e t t e r s the same variants contribute to multiple diseases or when different variants in the same gene confer susceptibility to different autoimmune diseases. Thus, dense mapping of as many susceptibility loci as possible will be important to understand how individual variants contribute to risk of disease. To facilitate these efforts, a custom Illumina Infinium genotyping array has been designed by the Immunochip Consortium on the basis of confirmed risk loci for 12 autoimmune diseases 15 , not including JIA. The chip includes dense coverage of the extended HLA region and 186 non-HLA loci 15 . In this study, we report an Immunochip analysis of 2,816 individuals with oligoarticular or rheumatoid factor (RF)-negative polyarticular JIA and 13,056 controls after quality control (Supplementary Tables 1 and 2) . There was overlap in the samples used in this study and in previous genetic studies of JIA [5] [6] [7] [8] [9] [10] [11] [12] 14 (for further details, see Online Methods). Restriction to these two subtypes (~70% of JIA cases) reduces phenotypic heterogeneity. Given that JIA is a complex genetic disorder that shares risk loci with other autoimmune diseases, the Immunochip provides a unique opportunity to discover new JIA risk loci. In addition, the dense coverage of many regions allows for fine mapping to identify possible causal variants and help inform future studies into the functional roles of JIA risk loci.
After stringent data quality control ( Supplementary Table 3 ), 123,003 SNPs with minor allele frequency (MAF) ≥ 1% were available for analysis. The inflation factor (λ GC ; calculated using a set of SNPs included on the Immunochip for a study investigating the genetic basis of reading and writing ability) for this study was 1.191 (λ GC−1,000 = 1.041). Seventeen of the 187 autoimmune disease regions investigated were significantly associated with oligoarticular and RF-negative polyarticular JIA (P < 5 × 10 −8 ) ( Fig. 1, Table 1 and Supplementary  Fig. 1) . These data strengthen the associations for 3 established JIA susceptibility loci (the HLA region, PTPN22 and PTPN2) and provide evidence for an additional 14 regions that reached genome-wide significance for the first time. For the three established associations, the most significant associations were observed within the major histocompatibility complex (MHC) region (Fig. 2) . Specifically, rs7775055 (MAF controls = 2%) showed the strongest evidence of association with JIA (odds ratio (OR) = 6.01; P = 3.14 × 10 −174 ). In addition, stepwise logistic regression identified 14 SNPs that showed separate effects in the region ( Supplementary Table 4 ). The most significant SNP, rs7775055, tagged the HLA-DRB1*0801-HLA-DQA1*0401-HLA-DQB1*0402 haplotype, which has been consistently implicated in conferring risk of JIA 16, 17 ; however, other HLA haplotypes have also been associated with JIA. The HLA region SNP rs7775055 showed a highly significant difference in SNP allele frequency between the two subtypes ( Supplementary Table 5 ). Association was stronger in the oligoarticular subtype compared to the RF-negative polyarticular subtype, consistent with previous studies showing differences in HLA region associations between the two subtypes 16, 17 . Further analysis at the amino-acid level is necessary to fully understand this complex region in JIA and its subtypes. The most significant association outside the MHC region was with rs6679677 (OR = 1.59; P = 3.19 × 10 −25 ) at 1p13.2, which contains the PTPN22 gene; rs6679677 is in linkage disequilibrium (LD; r 2 = 1) with rs2476601, the SNP previously associated with JIA 5,7 and implicated as the PTPN22 causal variant 18 . We also confirmed association with PTPN2 at rs2847293 (OR = 1.31; P = 1.44 × 10 −12 ), which lies in the intergenic region 3′ of PTPN2 and is in LD (r 2 = 0.94) with rs1893217, a SNP previously associated with oligoarticular and RF-negative polyarticular JIA 5 . Stepwise logistic regression including the most significant SNP in the PTPN2 region as a covariate suggested that there is an uncommon variant, rs149850873 (MAF controls = 2%), that confers an independent secondary effect in the region ( Supplementary Fig. 2 and Supplementary Table 6 ).
Of the 14 loci newly confirmed as JIA susceptibility loci in this study at the genome-wide significance level (P < 5 × 10 −8 ) ( Fig. 1 , Table 1 and Supplementary Fig. 1 ), 5 (STAT4, ANKRD55, IL2-IL21, IL2RA and SH2B3-ATXN2) have supporting evidence of a role in JIA susceptibility from previous studies. The most significant SNP in the STAT4 region (rs10174238) is in high LD with a SNP (rs7574865) previously reported in JIA 5, 8, 10 and other autoimmune diseases 19 . However, stepwise logistic regression analysis suggested the presence of two additional independent effects (rs45539732 and rs13029532), which are located within the adjacent STAT1 gene ( Supplementary  Fig. 3 and Supplementary Table 6 ). Notably, rs45539732 is an uncommon SNP (MAF controls = 3%).
There were 11 additional regions showing suggestive evidence (5 × 10 −8 < P < 1 × 10 −6 ) of association with oligoarticular and RF-negative npg l e t t e r s polyarticular JIA (Table 2) , of which 4 have supportive evidence from previous studies (COG6, CCR1-CCR3, TIMMDC1 (also known as C3orf1)-CD80 and AFF3-LONRF2).
We imputed across the non-HLA JIA risk loci identified in this study using 1000 Genomes Project data (Tables 1 and 2, Online Methods and Supplementary Fig. 1 ). We found only modest differences between the P values of the top genotyped SNP and the top imputed SNP at each locus. We note two regions that are minor exceptions: PRM1-RMI2 (also known as C16orf75) and C5orf56-IRF1 ( Supplementary  Fig. 1 ). In the latter region, the top imputed SNP lies within the C5orf56 gene. The lack of a substantial gain of information from imputation of the regions is consistent with other reports on the performance of Immunochip imputation 20, 21 . This is likely owing to the dense fine mapping of most regions represented on the Immunochip.
Of the top 17 regions that reached genome-wide significance, 13 were densely mapped on the Immunochip. LD patterns and functional annotation provided strong evidence that the signal localized to a single gene in eight loci (PTPN2, IL2RA, STAT4, IL2RB and ZFP36L1 based on LD patterns and PTPN22, SH2B3-ATXN2 and TYK2 based on the most significant SNP being a nonsynonymous coding variant) ( Table 3 , Supplementary Fig. 1 and Supplementary Table 7) ; however, further functional analysis is required for confirmation.
All but one of the variants that reached genome-wide significance were common (MAF > 5%). One variant, a nonsynonymous coding variant within TYK2, had a low allele frequency (MAF controls = 5%). In addition, a couple of the secondary effects in PTPN2 and STAT4 were uncommon.
In three regions (TYK2, SH2B3-ATXN2 and LTBR), the most significant SNP (or a SNP with r 2 > 0.9) was located within a coding region and is therefore a strong candidate for the causal variant.
For SH2B3-ATXN2, the same variant has also been associated with celiac disease 22 , vitiligo 23 , rheumatoid arthritis 24 , type 1 diabetes 25 and multiple sclerosis 26 . The TYK2 SNP (rs34536443) was also the lead SNP in the region in rheumatoid arthritis 27 , primary biliary cirrhosis 20 and psoriasis 28 . Other regions (IL6R, ZEP36L1, IL2-IL21, UBE2L3, LTBR and TIMMDC1-CD80) contain SNPs that show evidence of high mammalian conservation (17-way vertebrate conservation) 29 or have a high regulatory potential score (Table 3) , calculated using alignments of 7 mammalian genomes 30 . There is evidence that the associated SNPs in LTBR, UBE2L3 and LNPEP are expression quantitative trait loci (eQTL) ( Table 3 ). The SNP in LNPEP, rs27290, . IL2RA, the IL2-IL21 region and IL2RB are now all considered to be confirmed susceptibility loci for JIA and suggest an important role for the IL-2 pathway in JIA disease pathogenesis. This pathway has a vital role in T cell activation and development, as well as a key role in maintaining immune tolerance through the dependence of regulatory T cells on IL-2. Other confirmed JIA loci identified here are related to this pathway: SH2B3 encodes an adaptor protein involved in T cell activation, and STAT4 encodes a transcription factor important in T cell differentiation.
We next considered the top non-HLA SNP associations separately for each JIA subtype (oligoarticular and RF-negative polyarticular JIA). Only one region (C5orf56-IRF1) showed evidence of differential association, with the association limited to the oligoarticular subtype of JIA. All other regions showed associations with similar effect sizes and directions of effect in the two subtypes ( Supplementary Table 5 ). [35] [36] [37] Shown are SNPs in strong LD (r 2 > 0.9) with the lead SNP on the Immunochip with evidence of either strong regulatory potential (>0.35) 30 or conservation (>0.998) 29 .
a Coordinates are based on the NCBI37 assembly. b Functional prediction is based on PolyPhen 38 . c Data from three studies were considered: lymphoblastoid cell lines (LCLs) from HapMap 3 (Stranger et al. 35 ), fibroblast, LCLs and T cells from the umbilical cords of 75 Geneva Gencord individuals (Dimas et al. 36 ) and adipose, LCLs and skin from 856 healthy female twins of the MuTHER Resource (Grundberg et al. 37 ). Yes indicates evidence of an eQTL (P < 1 × 10 −3 ).
npg l e t t e r s
As expected, many of the JIA-associated regions shown in Tables 1 and 2 are also associated with other autoimmune diseases ( Supplementary Table 8 ), with the same SNP or a highly correlated SNP associated with the same direction of effect (assessed by comparing our results with information from the Catalog of Published GWAS and recent studies using the Immunochip in other autoimmune diseases [20] [21] [22] 27, 28, 32, 33 ). We found a strong overlap with rheumatoid arthritis risk loci, which is not unexpected owing to the clinical similarities with JIA, which is consistent with previous studies 8, 10, 34 . In addition, there was notable overlap with type 1 diabetes and celiac disease. Some regions (IL2-IL21, C5orf56-IRF1, IL2RB, ATP8B2-IL6R, 13q14, CCR1-CCR3, RUNX3 and TIMMDC1-CD80) showed association with other autoimmune diseases, but the top SNPs for the latter were not highly correlated with the most strongly associated SNPs for JIA. Some regions have not previously been associated with autoimmune diseases by GWAS or Immunochip at genome-wide significance. In-depth analysis of the results across all Immunochip studies will be of great value in understanding the contributions of the individual loci to the various diseases.
This study of 2,816 JIA cases is the largest collaborative cohort study of JIA so far and includes samples from across the United States, UK and Germany. The power derived from this cohort plus the large control sample size, combined with the comprehensive coverage of SNPs in regions implicated in autoimmune disease on the Immunochip, has substantially increased our ability to detect associations. In setting the statistical threshold at a stringent genome-wide significance level (P < 5 × 10 −8 ), we report 14 new loci. In addition, a second tier of 11 regions with suggestive evidence of association (P < 1 × 10 −6 ) has been identified that includes plausible candidate risk factors but requires validation. This study substantially increases the number of confirmed susceptibility loci for JIA, but additional genetic risk factors likely remain to be discovered, an idea supported by the quantile-quantile plot (Supplementary Fig. 4 ) that suggests that there are residual associations after removing those of the above implicated regions. In addition, we calculated that the entire Immunochip content, the HLA region and the top 27 loci explain an estimated 18, 13 and 6% of risk of JIA, respectively. These estimates also suggest that there must be other regions of the genome harboring additional JIA risk loci. In summary, this analysis using the Immunochip has substantially enhanced understanding of the genetic component of JIA, increasing the number of confirmed JIA susceptibility loci from 3 to 17. The dense mapping of confirmed regions has narrowed down the regions to be taken forward into future functional studies. Notably, these studies allow us to begin to understand where JIA fits within the spectrum of autoimmune diseases and identifies a number of new genes and pathways as potential targets for future therapeutic intervention.
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